
Keywords: Chemotherapy; Health-related quality of life; High-grade glioma; KPS; Recurrence therapy; Recurrent surgery; Re-radiation; Bev; Bevacizumab; CCNU; Lomustine; EORTC QLQ-BN20; European Organisation for Research and Treatment of Cancer Quality of Life Questi